Depression, Depressive Disorder, Depressive Disorder, Major, Depressive Disorder, Treatment-resistant
Conditions
Keywords
Depression, Major depression, Low-field magnetic stimulation, LFMS
Brief summary
The purpose of this study is to compare the relative effectiveness of 20 and 60 minutes of Low-Field Magnetic Stimulation in relieving symptoms in patients with major depression who are treatment resistant.
Detailed description
The primary objective of this study: * To compare the relative efficacy, as measured by a change in the 6-item Hamilton Rating Scale for Depression (HAM-D6), of 20 and 60 minutes of LFMS compared to sham (placebo) in subjects with treatment resistant depression (TRD). Secondary objectives: * To determine if subjects with TRD may respond to 120 minutes of LFMS. * To determine the persistence of response to LFMS therapy during the observation period. * To evaluate the safety and tolerability of LFMS.
Interventions
Low field magnetic stimulation (1 kilohertz oscillating magnetic field) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS. For sham therapy, the device will be on; however, no magnetic field stimulation will be delivered.
Sponsors
Study design
Eligibility
Inclusion criteria
(Key) * Meets the Diagnostic and Statistical Manual of Mental Disorder, 5th Edition (DSM-5) criteria for Major Depressive Disorder (MDD), as determined by psychiatric evaluation. * Has TRD of the current MDE, as assessed at the site by the Massachusetts General Hospital/Antidepressant Treatment Response Questionnaire (MGH/ATRQ). * On an adequate dose of one antidepressant therapy (ADT) for at least eight weeks prior to the screening visit (Visit 1). The ADT dose must be stable for at least four weeks prior to the screening visit (Visit 1). Subjects must be willing to remain on the same stable dose of ADT upon signing the informed consent form until the end of the treatment observation period (end of Week 2) and, where possible, to the end of study participation
Exclusion criteria
(Key) * Have failed four or more lifetime adequate ADT treatment regimens (including the ongoing ADT for the current MDE). * Have been treated with adjunctive antipsychotic medication with an antidepressant for at least two weeks during the current depressive episode. * Are deemed to be at significant risk for suicidal behavior * Are unable to lie on their back for the duration of study treatment * Have a lifetime history of: 1. Delirium, dementia, amnestic, or other cognitive disorder; 2. Schizophrenia or any psychotic disorder, based on the Structured Clinical Interview for DSM-5 Axis I Disorders Patient Edition (SCID-I/P); 3. Bipolar I or II disorder, based on the SCID-I/P. * Have a current DSM-5 diagnosis at the screening visit (Visit 1) of: 1. An eating disorder active within the 12 months prior to the screening visit (Visit 1); 2. Comorbid anxiety disorders that predominate over MDD, as assessed by the investigator; 3. Alcohol or substance use disorder active within the 12 months prior to the screening visit (Visit 1); 4. Clinically significant DSM-5 Axis II disorder. * Have ever received electroconvulsive therapy, vagal nerve stimulation, deep brain stimulation or repetitive transcranial magnetic stimulation. * Have a non-removable programmable device or appliance such as cardiac pacemakers or cochlear implants. * Have any non-removable ferromagnetic implants, or conductive or other magnetic sensitive materials present in the head or neck . * Have a lifetime history of seizures or clinically significant electroencephalography abnormalities. A history of childhood febrile seizures is permitted.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change From Baseline to ( Day 4) in the 6-item Hamilton Rating Scale for Depression (HAM-D6) Total Score. | Week 1 Day 4 | Hamilton Rating Scales for Depression were designed to measure the severity of depressive symptoms in subjects with primary depressive illness. HAM-D6 is a subset of the HAM-D17 that assesses 6 items associated with major depression. The scale uses HAM-D17 items 1, 2, 7, 8, 10 and 13. Item 13 is scored 0 to 2 and all others are scored 0 to 4. Total score ranges from 0 to 22; higher score indicates more depression. Change from baseline: mean score at Week 1 Day 4 minus mean score at baseline. Week 1 Day 4 : Change from baseline to the end of the efficacy period ( Day 4) in the 6-item Hamilton Rating Scale for Depression (HAM-D6) total score .Responders at Day 4 will be defined as those subjects who achieve a decrease in HAM-D6 total score of 50% or more compared to baseline (Day 1, Week 1). All other subjects will be deemed to be non-responders at Day 4. Each patient's total score is his/her own reference for determining a decrease of 50% or more. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change From Day 4 in HAM-D6 Total Score at Day 11 for Week 1 Non-responders: Response to 120 Minutes LFMS | Day 11 (Week 2) | Hamilton Rating Scales for Depression were designed to measure the severity of depressive symptoms in subjects with primary depressive illness. HAM-D6 is a subset of the HAM-D17 that assesses 6 items associated with major depression. The scale uses HAM-D17 items 1, 2, 7, 8, 10 and 13. Item 13 is scored 0 to 2 and all others are scored 0 to 4. Total score ranges from 0 to 22; higher score indicates more depression. Change from Day 11: mean score at Week 2 Day 11 minus mean score at Day 4. To determine if subjects with TRD who are non-responders to 0, 20 or 60 minutes of LFMS on Day 4 may respond to 120 minutes of LFMS at the end of Day 11. Responders will be defined as those subjects who achieve a decrease in HAM-D6 total score of 50% or more compared to baseline (Day 1, Week 1). All other subjects will be deemed to be non-responders. Each patient's total score is his/her own reference for determining a decrease of 50% or more. |
| Day 4 Responders: Persistence of Effect Based on Pre-specified HAM-D6 Total Score | Day 42 | To determine the persistence of response to LFMS therapy during a four-week follow-up period in subjects who were responders at Day 4. Persistence of response was achieved if during Week 2 post baseline visits and follow-up visits subjects' 6-item Hamilton Rating Scale for Depression (HAM-D6) total scores were lower than or equal to 50% of the baseline ( Day1 Week1) scores. Non-responder imputation method was used where missing post-baseline dichotomous (yes or no) were imputed as non-responder. Logistic regression model used to compare treatment groups for each visit, where the model considers the treatment, age and gender as covariates. |
Countries
United States
Participant flow
Recruitment details
12clinical study sites in the US recruited 122 subjects that were randomized into the study. The date of first subject enrollment was 03 September 2015 and the date of last subject enrolled was 22 July 2016.
Pre-assignment details
Subject screening period was up to 14 days before receiving first study treatment. Subjects were contacted by an independent Massachusetts General Hospital-Clinical Trials Network and Institute (MGH-CTNI) rater to perform the Antidepressant Treatment Response Questionnaire (ATRQ) and SAFER assessments to confirm eligibility.
Participants by arm
| Arm | Count |
|---|---|
| LFMS Sham For sham therapy, the device will be on; however, no magnetic field stimulation will be delivered. Low field magnetic stimulation (no magnetic field for sham) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS.
LFMS: Low field magnetic stimulation (1 kHz oscillating magnetic field) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS. For sham therapy, the device will be on; however, no magnetic field stimulation will be delivered. | 41 |
| LFMS 20 Minutes LFMS 20 minutes + Sham 40 min.Low field magnetic stimulation (1 kilohertz oscillating magnetic field) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS.
LFMS: Low field magnetic stimulation (1 kHz oscillating magnetic field) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS. For sham therapy, the device will be on; however, no magnetic field stimulation will be delivered. | 40 |
| LFMS 60 Minutes LFMS 60 minutes.Low field magnetic stimulation (1 kilohertz oscillating magnetic field) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS.
LFMS: Low field magnetic stimulation (1 kHz oscillating magnetic field) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS. For sham therapy, the device will be on; however, no magnetic field stimulation will be delivered. | 41 |
| LFMS 120 Min Week 2 subjects may be re-randomized to receive LFMS 120 minutes. Low field magnetic stimulation (1 kilohertz oscillating magnetic field) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS.
LFMS: Low field magnetic stimulation (1 kHz oscillating magnetic field) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS. For sham therapy, the device will be on; however, no magnetic field stimulation will be delivered. | 0 |
| Total | 122 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 | FG003 |
|---|---|---|---|---|---|
| Follow-up | Subject left town on Day 42 | 1 | 0 | 0 | 0 |
| Follow-up | Withdrawal by Subject | 0 | 0 | 0 | 1 |
| Week 1 Initial Randommization | Adverse Event | 1 | 0 | 0 | 0 |
| Week 1 Initial Randommization | Lost to Follow-up | 0 | 0 | 1 | 0 |
| Week 2 Stratification & Re-Randomization | Lost to Follow-up | 2 | 0 | 0 | 0 |
| Week 2 Stratification & Re-Randomization | Withdrawal by Subject | 0 | 0 | 0 | 2 |
Baseline characteristics
| Characteristic | LFMS Sham | LFMS 20 Minutes | LFMS 60 Minutes | LFMS 120 Min | Total |
|---|---|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 4 Participants | 5 Participants | 4 Participants | 0 Participants | 13 Participants |
| Age, Categorical Between 18 and 65 years | 37 Participants | 35 Participants | 37 Participants | 0 Participants | 109 Participants |
| Race/Ethnicity, Customized Asian | 1 Participants | 3 Participants | 2 Participants | 0 Participants | 6 Participants |
| Race/Ethnicity, Customized Black or African American | 9 Participants | 9 Participants | 11 Participants | 0 Participants | 29 Participants |
| Race/Ethnicity, Customized Other | 0 Participants | 0 Participants | 1 Participants | 0 Participants | 1 Participants |
| Race/Ethnicity, Customized White | 31 Participants | 28 Participants | 27 Participants | 0 Participants | 86 Participants |
| Sex: Female, Male Female | 23 Participants | 23 Participants | 26 Participants | 0 Participants | 72 Participants |
| Sex: Female, Male Male | 18 Participants | 17 Participants | 15 Participants | 0 Participants | 50 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk |
|---|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 79 | 0 / 40 | 0 / 41 | 0 / 41 |
| other Total, other adverse events | 20 / 79 | 14 / 40 | 13 / 41 | 10 / 41 |
| serious Total, serious adverse events | 0 / 79 | 0 / 40 | 0 / 41 | 0 / 41 |
Outcome results
Change From Baseline to ( Day 4) in the 6-item Hamilton Rating Scale for Depression (HAM-D6) Total Score.
Hamilton Rating Scales for Depression were designed to measure the severity of depressive symptoms in subjects with primary depressive illness. HAM-D6 is a subset of the HAM-D17 that assesses 6 items associated with major depression. The scale uses HAM-D17 items 1, 2, 7, 8, 10 and 13. Item 13 is scored 0 to 2 and all others are scored 0 to 4. Total score ranges from 0 to 22; higher score indicates more depression. Change from baseline: mean score at Week 1 Day 4 minus mean score at baseline. Week 1 Day 4 : Change from baseline to the end of the efficacy period ( Day 4) in the 6-item Hamilton Rating Scale for Depression (HAM-D6) total score .Responders at Day 4 will be defined as those subjects who achieve a decrease in HAM-D6 total score of 50% or more compared to baseline (Day 1, Week 1). All other subjects will be deemed to be non-responders at Day 4. Each patient's total score is his/her own reference for determining a decrease of 50% or more.
Time frame: Week 1 Day 4
Population: Subjects in the All Randomized set who completed at least one treatment session and had at least one post baseline primary efficacy assessment.
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| LFMS Sham | Change From Baseline to ( Day 4) in the 6-item Hamilton Rating Scale for Depression (HAM-D6) Total Score. | -4.0 units on a scale |
| LFMS 20 Minutes | Change From Baseline to ( Day 4) in the 6-item Hamilton Rating Scale for Depression (HAM-D6) Total Score. | -4.2 units on a scale |
| LFMS 60 Minutes | Change From Baseline to ( Day 4) in the 6-item Hamilton Rating Scale for Depression (HAM-D6) Total Score. | -4.9 units on a scale |
Change From Day 4 in HAM-D6 Total Score at Day 11 for Week 1 Non-responders: Response to 120 Minutes LFMS
Hamilton Rating Scales for Depression were designed to measure the severity of depressive symptoms in subjects with primary depressive illness. HAM-D6 is a subset of the HAM-D17 that assesses 6 items associated with major depression. The scale uses HAM-D17 items 1, 2, 7, 8, 10 and 13. Item 13 is scored 0 to 2 and all others are scored 0 to 4. Total score ranges from 0 to 22; higher score indicates more depression. Change from Day 11: mean score at Week 2 Day 11 minus mean score at Day 4. To determine if subjects with TRD who are non-responders to 0, 20 or 60 minutes of LFMS on Day 4 may respond to 120 minutes of LFMS at the end of Day 11. Responders will be defined as those subjects who achieve a decrease in HAM-D6 total score of 50% or more compared to baseline (Day 1, Week 1). All other subjects will be deemed to be non-responders. Each patient's total score is his/her own reference for determining a decrease of 50% or more.
Time frame: Day 11 (Week 2)
Population: Only non-responders at end of Day 4 comprise this Wk 2 analysis . (Non-responders were defined as those who didn't reach a decrease in 6-item Hamilton Rating Scale for Depression (HAM-D6) total score of 50% compared to baseline Day 1, Week 1). 41 subjects entered Week 2: 1 subject withdrew consent on Day 8 and was not part of the Full Analysis Set.
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| LFMS Sham | Change From Day 4 in HAM-D6 Total Score at Day 11 for Week 1 Non-responders: Response to 120 Minutes LFMS | -2.6 units on a scale |
| LFMS 20 Minutes | Change From Day 4 in HAM-D6 Total Score at Day 11 for Week 1 Non-responders: Response to 120 Minutes LFMS | -2.6 units on a scale |
Day 4 Responders: Persistence of Effect Based on Pre-specified HAM-D6 Total Score
To determine the persistence of response to LFMS therapy during a four-week follow-up period in subjects who were responders at Day 4. Persistence of response was achieved if during Week 2 post baseline visits and follow-up visits subjects' 6-item Hamilton Rating Scale for Depression (HAM-D6) total scores were lower than or equal to 50% of the baseline ( Day1 Week1) scores. Non-responder imputation method was used where missing post-baseline dichotomous (yes or no) were imputed as non-responder. Logistic regression model used to compare treatment groups for each visit, where the model considers the treatment, age and gender as covariates.
Time frame: Day 42
Population: Subjects who were HAM-D6 Day 4 responders, defined as those subjects who achieved a 50% or greater decrease in their HAM-D6 total score compared to Baseline ( Day1, Wk 1).
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| LFMS Sham | Day 4 Responders: Persistence of Effect Based on Pre-specified HAM-D6 Total Score | 53.8 percentage of LFMS responders |
| LFMS 20 Minutes | Day 4 Responders: Persistence of Effect Based on Pre-specified HAM-D6 Total Score | 57.1 percentage of LFMS responders |
| LFMS 60 Minutes | Day 4 Responders: Persistence of Effect Based on Pre-specified HAM-D6 Total Score | 78.6 percentage of LFMS responders |
Montgomery-Asberg Depression Rating Scale (MADRS): Change From Week 1 Baseline (Day 1) to End of Week 1 (Day 4)
The MADRS is a 10-item checklist designed to measure the overall severity of depressive symptoms in subjects with Major Depressive Disorder (MDD). Individual items are rated on a scale of 0 to 6 in which a score of 6 represents the most severe symptoms for each item assessed. The total score ranges from 0 to 60. Remission of depression based on the MADRS is defined as a subject with a MADRS total score of ≤11 at endpoint. A responder on the MADRS is defined as a 50% or greater reduction from baseline in total MADRS score
Time frame: Day 4 Week 1
Population: Full Analysis Set, Week1
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| LFMS Sham | Montgomery-Asberg Depression Rating Scale (MADRS): Change From Week 1 Baseline (Day 1) to End of Week 1 (Day 4) | -7.58 units on a scale |
| LFMS 20 Minutes | Montgomery-Asberg Depression Rating Scale (MADRS): Change From Week 1 Baseline (Day 1) to End of Week 1 (Day 4) | -8.09 units on a scale |
| LFMS 60 Minutes | Montgomery-Asberg Depression Rating Scale (MADRS): Change From Week 1 Baseline (Day 1) to End of Week 1 (Day 4) | -10.32 units on a scale |
Positive and Negative Affect Schedule (PANAS): Change From Baseline at Day 4 in Positive Score
The PANAS comprises two mood scales, one that measures positive affect and the other that measures negative affect. Used as a psychometric scale, the PANAS can show relationships between positive and negative affect with personality stats and traits. Descriptors are used to define their meanings. Subjects completing the PANAS are required to respond to a 20-item test using 5-point scale that ranges from very slightly or not at all (1) to extremely (5).To calculate the positive affect score, added scores on items 1, 3, 5, 9, 10, 12, 14, 16, 17, and 19. Scores can range from 10-50, which higher scores representing higher levels of positive affect, or the extent to which the individual feels enthusiastic, active and alert.
Time frame: Day 4 Week 1
Population: Full Analysis Set (Week 1).
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| LFMS Sham | Positive and Negative Affect Schedule (PANAS): Change From Baseline at Day 4 in Positive Score | 1.67 units on a scale |
| LFMS 20 Minutes | Positive and Negative Affect Schedule (PANAS): Change From Baseline at Day 4 in Positive Score | 3.62 units on a scale |
| LFMS 60 Minutes | Positive and Negative Affect Schedule (PANAS): Change From Baseline at Day 4 in Positive Score | 3.24 units on a scale |
Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at Day 4
The PANAS comprises two mood scales, one that measures positive affect and the other that measures negative affect. Subjects completing the PANAS are required to respond to a 20-item test using 5-point scale that ranges from very slightly or not at all (1) to extremely (5).Negative affect scores can be obtained by adding up scores for items 2, 4, 6, 7, 8, 11, 13, 15, 18 and 20. The negative affect score can range from 10 to 50, with lower scores representing lower level of negative affect, or the extent to which the individual feels aversive mood states and general distress. This analysis outcome treated Item #2 as random missing data.
Time frame: Day 4, Week 1
Population: Full analysis set, Week 1.Item #2 was incorrectly listed as Disinterested instead of Distressed.resulting in incorrect data for this item for the first 16 subjects. The PANAS data for the first 16 randomized subjects and in total 72 data points was identified and removed from the database. See stats analysis for further details.
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| LFMS Sham | Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at Day 4 | -2.27 units on a scale |
| LFMS 20 Minutes | Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at Day 4 | -3.57 units on a scale |
| LFMS 60 Minutes | Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at Day 4 | -5.32 units on a scale |
Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at Day 4
The PANAS comprises two mood scales, one that measures positive affect and the other that measures negative affect. Subjects completing the PANAS are required to respond to a 20-item test using 5-point scale that ranges from very slightly or not at all (1) to extremely (5).Negative affect scores can be obtained by adding up scores for items 2, 4, 6, 7, 8, 11, 13, 15, 18 and 20. The negative affect score can range from 10 to 50, with lower scores representing lower level of negative affect, or the extent to which the individual feels aversive mood states and general distress. This analysis outcome treated Incorrect Item #2 where Item #2 data was removed.
Time frame: Day 4
Population: Full analysis set, Week 1.Item #2 was incorrectly listed as Disinterested instead of Distressed.resulting in incorrect data for this item for the first 16 subjects. The PANAS data for the first 16 randomized subjects and in total 72 data points was identified and removed from the database. See stats analysis for further details.
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| LFMS Sham | Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at Day 4 | -2.95 units on a scale |
| LFMS 20 Minutes | Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at Day 4 | -3.78 units on a scale |
| LFMS 60 Minutes | Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at Day 4 | -5.58 units on a scale |
Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at End of Week 1, Day 4
The PANAS comprises two mood scales, one that measures positive affect and the other that measures negative affect. Subjects completing the PANAS are required to respond to a 20-item test using 5-point scale that ranges from very slightly or not at all (1) to extremely (5).Negative affect scores can be obtained by adding up scores for items 2, 4, 6, 7, 8, 11, 13, 15, 18 and 20. The negative affect score can range from 10 to 50, with lower scores representing lower level of negative affect, or the extent to which the individual feels aversive mood states and general distress. This analysis outcome approach took Incorrect Item #2 and imputed using worst possible value.
Time frame: Day 4, Week 1
Population: Full analysis set, Week 1.Item #2 was incorrectly listed as Disinterested instead of Distressed.resulting in incorrect data for this item for the first 16 subjects. The PANAS data for the first 16 randomized subjects and in total 72 data points was identified and removed from the database. See stats analysis for further details.
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| LFMS Sham | Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at End of Week 1, Day 4 | -2.29 units on a scale |
| LFMS 20 Minutes | Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at End of Week 1, Day 4 | -3.50 units on a scale |
| LFMS 60 Minutes | Positive and Negative Affect Schedule (PANAS) Change From Baseline in Negative Score at End of Week 1, Day 4 | -5.36 units on a scale |